34Inflectra

Delivering on the Potential of Biosimilar Medicines, The Role of Functioning Competitive Markets. 2016. [viewed: May 2018].
Available from: http://medicinesforeurope.com/wp-content/uploads/2016/03/IMS-Institute-Biosimilars-Report-March-2016-FINAL.pdf
 

English, British
Citation title: 
34. IMS Institute for Healthcare Informatics.
Brand: 
Inflectra® (infliximab) (en)